Ultragenyx is a pharmaceutical company in Novato, California, developing drug and gene therapy candidates for disease states. It last closed at $16.48 on Nov 20, down 4.30% on the day. The next earnings report for RARE is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, RARE reported EPS of -$1.16 on revenue of $173.0M, with revenue up 8.1% from a year ago. Over its last 8 reports the stock moved an average of 5.1% the session after earnings. Over the last 12 months RARE insiders bought $0 of stock on the open market and sold $3.8M, according to SEC Form 4 filings.
AI Auto Pilots
Is RARE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RARE.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RAREStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RARE · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend
The stock sits between its 20 and 50 day averages. It is 36% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 51). The nearest support is the Pivot S1 at $16.15, and the nearest resistance the Pivot at $16.75.
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 5.4%/day
Key levels
$39.8952 week high+142.1%
$22.34200 day average+35.6%
$20.92100 day average+26.9%
$17.08Pivot R1+3.6%
$16.77Swing high (Nov 11)+1.8%
$16.75Pivot+1.6%
$16.4820 day average+0.0%
$16.48Last close
$16.15Pivot S1−2.0%
$15.65Swing low (Nov 17)−5.0%
$15.5150 day average−5.9%
$12.7352 week low−22.8%
Indicators
RSI (14)
50.64
Middle of its range
Neutral
MACD
0.19
Above its signal line
Bullish
Stochastic
70.7
Middle of its range
Neutral
ADX (14)
19.6
No clear trend
Williams %R
-55.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
44.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+6.8%
Change over 10 sessions
Bullish
ATR (14)
$0.90
Typical daily range, 5.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 16.7%/day
Key levels
$39.8952 week high+142.1%
$22.34200 day average+35.6%
$20.92100 day average+26.9%
$17.08Pivot R1+3.6%
$16.77Swing high (Nov 11)+1.8%
$16.75Pivot+1.6%
$16.4820 day average+0.0%
$16.48Last close
$16.15Pivot S1−2.0%
$15.65Swing low (Nov 17)−5.0%
$15.5150 day average−5.9%
$12.7352 week low−22.8%
Indicators
RSI (14)
39.70
Weak, oversold below 30
Neutral
MACD
-2.75
Below its signal line
Bearish
Stochastic
20.7
Middle of its range
Neutral
ADX (14)
22.6
Weak trend
Williams %R
-76.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-43.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+15.2%
Change over 10 sessions
Bullish
ATR (14)
$2.76
Typical daily range, 16.7% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for RARE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RARE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RARE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RAREHow many large options trades hit RARE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RARE in the last 90 days.
From SEC Form 4 filings by RARE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RARE is in one of them and how their past RARE trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Ultragenyx Pharmaceutical
Ultragenyx is a pharmaceutical company based in Novato, California. It is developing drug candidates, including gene therapy candidates that use AAV vectors, for a range of disease states. Its work is aimed at patients, physicians and healthcare providers who would use any approved treatments, and it works with regulators such as the FDA and the EMA to define approval paths.